RIGL - Rigel raises 2025 revenue guidance to $285M-$290M as commercial sales growth accelerates
2025-11-04 20:07:15 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript
- Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion
- Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout
- Rigel Pharmaceuticals GAAP EPS of $1.46 beats by $0.56, revenue of $69.46M beats by $7.58M
- Seeking Alpha’s Quant Rating on Rigel Pharmaceuticals